Strides Arcolab likely to sell Australian branded-generics unit

09 Jan 2012 Evaluate

Strides Arcolab, the Indian drug maker is likely to sell its Australian branded-generics unit, Ascent Pharmahealth. The company is also considering the divestment of other businesses such as softgel and anti-retro viral drug manufacturing, as the drug maker wants to focus on specialty injectables. US investment bank Jefferies and Co is advising Strides Arcolab for the divestments.

Ascent Pharmahealth is one of the largest branded generic drugmakers in Australia, with 13% market share. It also has a significant presence in Singapore, Thailand and Vietnam. In 2010, the business had sales of $140 million.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

910.45 -27.95 (-2.98%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×